According to the NIH, immunoglobulin A nephropathy (IgAN), also called Berger’s disease, is
one of the most common chronic kidney diseases worldwide. It develops when IgA antibodies—
normally part of the body’s immune defense—build up in the kidneys and cause inflammation.
Over time, this inflammation can lead to excess protein in the urine and a decline in kidney
function, and in some cases may progress to kidney failure.
While there are treatments available to treat IgAN, they do not always work well for everyone,
and some people may have side effects or other medical conditions that prevent them from
taking them.
The purpose of this study is to evaluate an investigational drug to see whether adding it to
current treatments may help protect kidney function and safely reduce protein levels in the urine.
Researchers want to understand whether this approach may offer additional benefit compared to
standard treatment alone.
This clinical research study is enrolling adults who have been taking prescribed IgAN
medication for at least three months, or who have not been able to tolerate these medications due
to side effects. There is no charge to participate, and compensation may be available for study-related expenses.
If you’re not sure whether you meet study criteria, we encourage you to reach out. A member of
the study team can review your history and help determine whether this study may be an option
for you.
You may be able to join if you:
This is not a complete list of requirements for participation. If you provide us with your contact information, we will promptly reach out to provide you with more information about our research study.
Participants who satisfy applicable requirements may be compensated for their time and expenses. The amount of compensation available and the applicable requirements will be discussed by the staff at the research center.
If you are interested in participating or just wish to learn more, please provide your contact information. Our goal is to contact all people who submit a contact form within two business days after submission.
Doctors and scientists are constantly discovering new medications and devices that may help prevent, detect, diagnose, control, and treat illnesses. A research study or clinical trial is a scientific study that tests these new discoveries. Research studies depend upon the participation of volunteers.
There is no guarantee that participants will receive any benefit from participating in this study. However, this research study may yield new information that could benefit people in the future by helping to answer questions about the effectiveness and safety of the investigational drug.
Participation in a research study is completely voluntary. In all research studies, qualified potential participants are first informed about the research study in detail. After receiving this information, all participants must give their consent in writing to proceed. Some research studies involve more tests and doctor visits than the participant would normally have for an illness or condition.
Health insurance is NOT required to participate.
You will not be charged for the investigational drug, study-related procedures and tests, or study
visits.
Before participating in a research study, volunteers must meet specific requirements. These requirements are based on various factors, such as age, medical history, current health status, current medications, and allergies. The circumstances that allow a person to participate are called Inclusion Criteria and those that prevent participation are called Exclusion Criteria. These requirements are used to ensure the accuracy of the study as well as the safety of all participants. We will not know whether you satisfy all study requirements until we speak with you and, if appropriate, complete a screening assessment at our facilities.
ClinTrial Research is staffed by experienced medical personnel that are committed to each patient’s health as well as to helping find treatments that can help patients in the future.
ClinTrial Research conducts studies at the following location:
ClinTrial Research
3885 Oakwater Circle
Suite B
Orlando, FL 32806
(MAP)
